Principles of Psychopharmacology

Principles of Psychopharmacology

Principles of Psychopharmacology

On this page

PK Essentials - Drug's Grand Tour

  • Absorption: Bioavailability (F); IV = 100%. First-pass metabolism impacts F.
  • Distribution: Volume of Distribution ($V_d = \text{Dose} / C_0$). Protein binding (unbound drug active). BBB crossing (lipophilic drugs).
  • Metabolism: Hepatic. Phase I (CYP450: oxidation, reduction, hydrolysis), Phase II (conjugation).
    • CYP Inducers: 📌 CRAP GPS (e.g., Carbamazepine, Rifampicin). ↓ drug effect.
    • CYP Inhibitors: 📌 SICKFACES.COM (e.g., Valproate, Fluconazole). ↑ drug effect/toxicity.
  • Excretion: Primarily renal. Clearance (CL). Half-life ($t_{1/2} = (0.693 \times V_d) / CL$). Steady state: 4-5 $t_{1/2}$. Pharmacokinetics: The principles of ADME
  • Special Populations: Elderly (↓ clearance, altered $V_d$), Pediatrics (enzyme immaturity).

⭐ Most psychotropics are lipophilic and highly protein-bound, influencing $V_d$ and duration of action.

PD Unveiled - Brain's Chat Room

  • Core Principle: Drug binds to target (e.g., receptor) → alters cellular function → therapeutic/adverse effect.
  • Receptor Interactions:
    • Agonist: Activates receptor (e.g., SSRIs ↑ 5-HT effect indirectly).
    • Antagonist: Blocks receptor (e.g., antipsychotics block D₂ receptors).
      • Competitive: Reversible; overcome by ↑ agonist concentration.
      • Non-competitive: Irreversible/allosteric; ↓ Emax.
    • Partial Agonist: Submaximal response (e.g., aripiprazole at D₂).
    • Inverse Agonist: Effect opposite to agonist (e.g., some antihistamines).
  • Dose-Response: Relationship between drug dose & effect.
    • Potency: Dose for 50% maximal effect (ED₅₀).
    • Efficacy: Maximum possible effect (Emax).
    • Therapeutic Index (TI): $TI = TD₅₀/ED₅₀$ (Ratio of toxic dose to therapeutic dose; safety margin).
  • Key Neurotransmitters (NTs): Dopamine (DA), Serotonin (5-HT), GABA, Norepinephrine (NE).

Ligand-receptor binding curves

⭐ Receptor occupancy by a drug does not always correlate linearly with clinical response due to factors like spare receptors, signal amplification, and individual patient variability in downstream pathways and metabolism.

ADRs & Alerts - Safety First Crew

  • Serotonin Syndrome: Triad (Cognitive, Autonomic, Neuromuscular - myoclonus, hyperreflexia, tremor). Manage: Stop agent, Cyproheptadine.
  • NMS (Neuroleptic Malignant Syndrome): 📌FEVER (Fever, Encephalopathy, Vitals unstable, Enzymes ↑CPK, Rigidity "lead-pipe"). Manage: Stop antipsychotic, Dantrolene/Bromocriptine.
  • Lithium Toxicity: Levels > 1.5 mEq/L (Therapeutic $0.6-1.2$ mEq/L). GI, neuro (ataxia, confusion). Dialysis if > 2.5 mEq/L or severe.
  • Clozapine: Agranulocytosis (ANC < 1500/µL), myocarditis, seizures, metabolic syndrome.
  • Lamotrigine: Stevens-Johnson Syndrome (SJS)/TEN. ⚠️ Slow dose titration essential to minimize risk.
  • TCAs: Cardiotoxicity (QRS > 100ms), anticholinergic, orthostasis. 📌 "Tri-C's": Coma, Convulsions, Cardiotoxicity.
  • General: Monitor vitals, labs (LFT, KFT, CBC), ECG. Beware CYP450 Drug-Drug Interactions (DDI).

Neuroleptic Malignant Syndrome (NMS) Overview

⭐ Clozapine: Risk of agranulocytosis (ANC < 1500/µL or WBC < 3000/µL). Strict ANC monitoring vital.

Clinical Pearls - Pro Prescribing

⭐ Rational combinations: Maximize synergy (e.g., SSRI + Mirtazapine), minimize antagonism. Key for treatment resistance.

  • Special Populations: Pregnancy (risk-benefit), elderly (↓dose, monitor), hepatic/renal (dose adjust).

High‑Yield Points - ⚡ Biggest Takeaways

  • Pharmacokinetics (ADME) governs drug movement; lipid solubility aids CNS penetration.
  • Pharmacodynamics describes drug actions; receptor affinity and intrinsic activity are key.
  • CYP450 enzymes (e.g., 2D6, 3A4) are crucial for drug metabolism and interactions.
  • Half-life (t½) determines dosing interval and time to steady state (4-5 t½).
  • Therapeutic Index (TI) indicates drug safety; narrow TI drugs (Lithium) need TDM.
  • Serotonin syndrome and MAOI-tyramine reactions are critical drug interactions.
  • Consider age and pregnancy for dose adjustments and drug selection in psychopharmacology.

Practice Questions: Principles of Psychopharmacology

Test your understanding with these related questions

Variation in sensitivity of response to different doses of a drug in different individuals is obtained from?

1 of 5

Flashcards: Principles of Psychopharmacology

1/9

For prophylaxis of acute mania the blood levels of lithium should be _____ mEq/L

TAP TO REVEAL ANSWER

For prophylaxis of acute mania the blood levels of lithium should be _____ mEq/L

0.5-0.8

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial